Annual Total Liabilities
$22.04 M
-$6.79 M-23.54%
December 31, 2023
Summary
- As of February 22, 2025, SCNI annual total liabilities is $22.04 million, with the most recent change of -$6.79 million (-23.54%) on December 31, 2023.
- During the last 3 years, SCNI annual total liabilities has fallen by -$196.90 thousand (-0.89%).
- SCNI annual total liabilities is now -57.79% below its all-time high of $52.21 million, reached on December 1, 2019.
Performance
SCNI Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$2.26 M
-$19.88 M-89.80%
September 1, 2024
Summary
- As of February 22, 2025, SCNI quarterly total liabilities is $2.26 million, with the most recent change of -$19.88 million (-89.80%) on September 1, 2024.
- Over the past year, SCNI quarterly total liabilities has dropped by -$19.91 million (-89.81%).
- SCNI quarterly total liabilities is now -95.68% below its all-time high of $52.21 million, reached on December 1, 2019.
Performance
SCNI Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SCNI Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.5% | -89.8% |
| 3 y3 years | -0.9% | -92.2% |
| 5 y5 years | -39.4% | -92.2% |
SCNI Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.0% | at low | -92.7% | at low |
| 5 y | 5-year | -57.8% | at low | -95.7% | at low |
| alltime | all time | -57.8% | +7997.4% | -95.7% | +449.3% |
Scinai Immunotherapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.26 M(-89.8%) |
| Jun 2024 | - | $22.14 M(-0.1%) |
| Mar 2024 | - | $22.17 M(+0.6%) |
| Dec 2023 | $22.04 M(-23.5%) | $22.04 M(+3.6%) |
| Sep 2023 | - | $21.27 M(-21.2%) |
| Jun 2023 | - | $27.01 M(-3.9%) |
| Mar 2023 | - | $28.10 M(-2.5%) |
| Dec 2022 | $28.83 M(-7.2%) | $28.83 M(+57.2%) |
| Sep 2022 | - | $18.34 M(-21.5%) |
| Jun 2022 | - | $23.36 M(-6.4%) |
| Mar 2022 | - | $24.95 M(-19.7%) |
| Dec 2021 | $31.05 M(+39.6%) | - |
| Dec 2021 | - | $31.05 M(+30.1%) |
| Sep 2021 | - | $23.86 M(+1.3%) |
| Jun 2021 | - | $23.55 M(+6.4%) |
| Mar 2021 | - | $22.14 M(-0.5%) |
| Dec 2020 | $22.24 M(-57.4%) | $22.24 M(-0.1%) |
| Sep 2020 | - | $22.26 M(-48.0%) |
| Jun 2020 | - | $42.83 M(-18.0%) |
| Dec 2019 | $52.21 M | $52.21 M(+30.1%) |
| Sep 2019 | - | $40.12 M(-3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $41.49 M(+15.8%) |
| Mar 2019 | - | $35.82 M(-1.6%) |
| Dec 2018 | $36.39 M(+397.1%) | $36.39 M(+98.4%) |
| Sep 2018 | - | $18.34 M(+51.9%) |
| Jun 2018 | - | $12.07 M(+41.6%) |
| Mar 2018 | - | $8.53 M(+16.5%) |
| Dec 2017 | $7.32 M(+526.6%) | $7.32 M(+71.7%) |
| Sep 2017 | - | $4.26 M(-26.3%) |
| Jun 2017 | - | $5.78 M(+71.7%) |
| Mar 2017 | - | $3.37 M(+188.2%) |
| Dec 2016 | $1.17 M(-41.2%) | $1.17 M(-3.5%) |
| Sep 2016 | - | $1.21 M(-24.1%) |
| Jun 2016 | - | $1.59 M(-2.5%) |
| Mar 2016 | - | $1.64 M(-17.8%) |
| Dec 2015 | $1.99 M(+313.0%) | $1.99 M(-5.4%) |
| Sep 2015 | - | $2.10 M(-16.3%) |
| Jun 2015 | - | $2.51 M(+484.9%) |
| Mar 2015 | - | $429.10 K(-10.9%) |
| Dec 2014 | $481.50 K(-8.7%) | $481.50 K(+17.1%) |
| Sep 2014 | - | $411.10 K(-22.1%) |
| Dec 2013 | $527.50 K(+93.8%) | $527.50 K |
| Dec 2012 | $272.20 K | - |
FAQ
- What is Scinai Immunotherapeutics annual total liabilities?
- What is the all time high annual total liabilities for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics annual total liabilities year-on-year change?
- What is Scinai Immunotherapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly total liabilities year-on-year change?
What is Scinai Immunotherapeutics annual total liabilities?
The current annual total liabilities of SCNI is $22.04 M
What is the all time high annual total liabilities for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual total liabilities is $52.21 M
What is Scinai Immunotherapeutics annual total liabilities year-on-year change?
Over the past year, SCNI annual total liabilities has changed by -$6.79 M (-23.54%)
What is Scinai Immunotherapeutics quarterly total liabilities?
The current quarterly total liabilities of SCNI is $2.26 M
What is the all time high quarterly total liabilities for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly total liabilities is $52.21 M
What is Scinai Immunotherapeutics quarterly total liabilities year-on-year change?
Over the past year, SCNI quarterly total liabilities has changed by -$19.91 M (-89.81%)